{"uri": "eng-9428759", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Viral_hepatitis", "type": "wiki", "score": 100, "label": {"eng": "Viral hepatitis"}}, {"uri": "http://en.wikipedia.org/wiki/Hepatitis", "type": "wiki", "score": 75, "label": {"eng": "Hepatitis"}}, {"uri": "http://en.wikipedia.org/wiki/Liver", "type": "wiki", "score": 41, "label": {"eng": "Liver"}}, {"uri": "http://en.wikipedia.org/wiki/Hepatitis_A", "type": "wiki", "score": 32, "label": {"eng": "Hepatitis A"}}], "eventDate": "2024-03-25", "totalArticleCount": 7, "title": {"eng": "Hepatitis C Treatments on the Horizon"}, "summary": {"eng": "\"A number of companies are trying to develop other drugs with greater ease of administration and cost,\" says Thomas D. Boyer, MD. He's the director of the Liver Research Institute at the University of Arizona Medical Center in Tucson.\n\nThe latest drug to be approved, Harvoni (ledipasvir and sofosbuvir), is a once-a-day pill that can cure hepatitis C in eight, 12, or 24 weeks (depending on the individual) with mild side effects. Before Harvoni was approved, most people with hepatitis C needed inte"}, "location": null, "categories": [{"uri": "dmoz/Health/Conditions_and_Diseases/Infectious_Diseases", "label": "dmoz/Health/Conditions and Diseases/Infectious Diseases", "wgt": 62}, {"uri": "dmoz/Health/Conditions_and_Diseases/Digestive_System_Disorders", "label": "dmoz/Health/Conditions and Diseases/Digestive System Disorders", "wgt": 43}, {"uri": "news/Health", "label": "news/Health", "wgt": 71}], "articleCounts": {"eng": 7}, "sentiment": -0.0117647058823529, "wgt": 449020800, "relevance": 1}